Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid.
Increasing use of short-course antifungal therapies in patients with recurrent vulvovaginitis may enable the emergence of less-common, more resistant yeast strains as vaginal pathogens. We report the case of a patient with chronically symptomatic and repeatedly treated vaginal candidiasis whose infection was attributable to Candida lusitaniae, a previously unreported cause of candidal vaginitis.
Silverman
N S
NS
Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Burns & Allen Research Institute, UCLA School of Medicine, Los Angeles, CA 90048, USA. silvermann@cshs.org
Morgan
M
M
Nichols
W S
WS
D000282:Administration, Intravaginal; D001888:Boric Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida / Q000145:classification* / Q000254:growth & development / Q000378:metabolism; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000382:microbiology*; D005260:Female; D006801:Humans; D008875:Middle Aged
D001888:Boric Acids; C032688:boric acid